Agro-biotechnology company Rosetta Green Ltd. (TASE: RSTG), one of the newest listings on the TASE, today announced success in a preliminary trial of drought-resistant potatoes.
The potatoes were enhanced with the micro-RNA gene RGN-131, which the company found can potentially improve the potatoes' resistance to drought and severe environmental conditions. The trial found that the RGN-131 potatoes had significantly better survival capability and drought adaptability than the potatoes in the control group.
"We have marked an important achievement. The successful trial results are an important milestone for enhancing plants' capabilities in extreme conditions," said Rosetta Green CEO Amir Avniel. "Improving crops' survivability is a critical field in global agriculture."
Rosetta Green is a spinoff of Rosetta Genomics Ltd. (Nasdaq:ROSG), and operates in the same field as Evogene Ltd. (TASE:EVGN).
Rosetta Green's share price 2.6% by mid-afternoon on the TASE to NIS 4.58, giving a market cap of NIS 48 million.
Published by Globes [online], Israel business news - www.globes-online.com - on March 9, 2011
© Copyright of Globes Publisher Itonut (1983) Ltd. 2011